phrykt

Progyny, Inc. (PGNY): who owns it and who trades it

As of Nov 16, 2026, PGNY insiders reported 38 open-market sales worth $24.5M and no purchases in the last 12 months, with 96% of the sale value made under pre-set 10b5-1 plans. The largest seller was Peter Anevski (CEO), with $14.7M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Progyny

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PGNY

311 funds and institutions reported PGNY shares worth $2.4B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 14.8%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.14.8%
FMR LLC (Fidelity)8.9%
Vanguard Portfolio Management LLC6.4%
Vanguard Capital Management LLC4.1%
State Street Corp3.9%
Ameriprise Financial Inc3.5%
Fort Washington Investment Advisors Inc3.3%
California State Teachers Retirement System3.1%
Geode Capital Management, LLC2.5%
Citadel Advisors LLC2.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.11.60M14.81%$334M-3%
FMR LLC (Fidelity)7.00M8.94%$202M+8%
Vanguard Portfolio Management LLC5.02M6.41%$145M-5%
Vanguard Capital Management LLC3.21M4.10%$92.6M-8%
State Street Corp3.02M3.86%$87.1M-2%
Ameriprise Financial Inc2.76M3.53%$79.7M-2%
Fort Washington Investment Advisors Inc2.55M3.25%$73.5M-5%
California State Teachers Retirement System2.39M3.06%$83M+2299%
Geode Capital Management, LLC1.97M2.51%$56.8M-4%
Citadel Advisors LLC1.79M2.28%$51.5M–
Dimensional Fund Advisors LP1.69M2.16%$48.7M+7%
Soleus Capital Management, L.P.1.60M2.05%$46.2M-22%
Morgan Stanley1.54M1.96%$44.3M-33%
Wellington Management Group LLP1.50M1.91%$43.1M-35%
Disciplined Growth Investors Inc1.18M1.51%$34.1M+106%
Loomis Sayles & Co L P1.08M1.38%$31.2M+9%
Baillie Gifford & Co1.08M1.38%$31.1M-12%
Jane Street Group, LLC1.06M1.36%$30.7M+614%
Easterly Investment Partners LLC958,1171.22%$27.6M+15%
Charles Schwab Investment Management Inc954,0651.22%$27.5M+19%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, PGNY insiders reported $0 of open-market purchases and $24.5M of sales. 96% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$24.5M
38 trades, 8 people
Sales under a 10b5-1 plan
96%
Share of sale value
Latest trade
Nov 11, 2026
Filed Nov 13, 2026

Purchases and sales by month

$21.9M$21.9MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 11, 2026Geoffrey ClappChief Product OfficerSale plan774$36.41$28.2KForm 4
Nov 10, 2026Peter AnevskiCEOSale plan120,213$35.61$4.3MForm 4
Nov 10, 2026Peter AnevskiCEOSale plan64,921$36.29$2.4MForm 4
Nov 10, 2026Peter AnevskiCEOSale plan33,437$35.61$1.2MForm 4
Nov 10, 2026Peter AnevskiCEOSale plan18,059$36.29$655KForm 4
Nov 10, 2026David J SchlangerChairSale plan35,392$35.36$1.3MForm 4
Nov 9, 2026Peter AnevskiCEOSale plan126,204$35.73$4.5MForm 4
Nov 9, 2026Peter AnevskiCEOSale plan35,104$35.73$1.3MForm 4
Nov 9, 2026David J SchlangerChairSale plan161,208$35.73$5.8MForm 4
Nov 5, 2026Peter AnevskiCEOSale plan3,400$35.23$120KForm 4
Nov 5, 2026Peter AnevskiCEOSale plan8,539$35.09$300KForm 4
Nov 5, 2026David J SchlangerChairSale plan3,400$35.22$120KForm 4
Nov 4, 2026Mark S. LivingstonCFOSale plan2,139$30.00$64.2KForm 4
Oct 14, 2026Melissa B CummingsChief Operating OfficerSale plan1,879$28.00$52.6KForm 4
Sep 23, 2026Allison SwartzVice presidentSale plan3,903$26.10$102KForm 4
Sep 10, 2026Kevin K GordonDirectorSale11,500$27.12$312KForm 4
Sep 10, 2026Kevin K GordonDirectorSale11,500$27.94$321KForm 4
Jul 14, 2026Melissa B CummingsChief Operating OfficerSale plan2,244$31.60$70.9KForm 4
Jun 4, 2026Mark S. LivingstonCFOSale plan599$25.50$15.3KForm 4
Jun 4, 2026Mark S. LivingstonCFOSale plan1,918$25.50$48.9KForm 4
Jun 4, 2026Allison SwartzVice presidentSale plan599$25.08$15KForm 4
Jun 3, 2026Allison SwartzVice presidentSale plan1,199$25.02$30KForm 4
Jun 2, 2026Mark S. LivingstonCFOSale plan279$26.20$7.3KForm 4
Jun 2, 2026Geoffrey ClappChief Product OfficerSale1,530$25.58$39.1KForm 4
Jun 1, 2026Cheryl ScottDirectorSale7,439$26.39$196KForm 4
May 28, 2026Allison SwartzVice presidentSale plan2,398$25.46$61.1KForm 4
May 27, 2026Kevin K GordonDirectorSale5,500$24.99$137KForm 4
May 20, 2026Mark S. LivingstonCFOSale plan8,275$25.50$211KForm 4
May 19, 2026Melissa B CummingsChief Operating OfficerSale plan9,578$25.00$239KForm 4
Mar 4, 2026Allison SwartzVice presidentSale plan599$17.54$10.5KForm 4
Mar 3, 2026Allison SwartzVice presidentSale plan4,157$17.40$72.3KForm 4
Mar 3, 2026Allison SwartzVice presidentSale plan500$17.40$8.7KForm 4
Mar 2, 2026Allison SwartzVice presidentSale plan2,199$17.27$38KForm 4
Dec 11, 2025Mark S. LivingstonCFOSale plan459$25.50$11.7KForm 4
Dec 4, 2025Allison SwartzVice presidentSale plan530$24.59$13KForm 4
Dec 2, 2025Mark S. LivingstonCFOSale plan213$25.50$5.4KForm 4
Nov 28, 2025Allison SwartzVice presidentSale plan2,398$26.87$64.4KForm 4
Nov 17, 2025Mark S. LivingstonCFOSale plan21,303$25.50$543KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Peter AnevskiCHIEF EXECUTIVE OFFICER, Director–$14.7MNov 10, 2026
David J SchlangerExecutive Chairman, Director–$7.1MNov 10, 2026
Mark S. LivingstonCHIEF FINANCIAL OFFICER–$907KNov 4, 2026
Kevin K GordonDirector–$771KSep 10, 2026
Allison SwartzEVP, GC–$415KSep 23, 2026
Melissa B CummingsChief Operating Officer–$363KOct 14, 2026
Cheryl ScottDirector–$196KJun 1, 2026
Geoffrey ClappChief Product Officer–$67.3KNov 11, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PGNY short interest

Moderate short interest. 6.2% of PGNY shares are sold short: about 1 share in 16. Over the last 12 reports the number of shares short went down 12%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 4.76M PGNY shares were sold short, 6.2% of the shares outstanding, down 1.9% from the report before. At the average daily volume of 760,534 shares, buying them all back would take about 6.3 trading days (days to cover).

Shares short, % of all shares

6.20%May 15Oct 307.10%

Days to cover

6.3May 15Oct 306.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20264.76M6.20%-2%760,5346.3
Oct 15, 20264.85M6.32%-5%1.14M4.2
Sep 30, 20265.09M6.64%+8%1.25M4.1
Sep 15, 20264.71M6.14%+6%1.02M4.6
Aug 31, 20264.45M5.80%-3%983,1214.5
Aug 14, 20264.57M5.96%+2%1.32M3.5
Jul 31, 20264.49M5.85%-3%972,1104.6
Jul 15, 20264.63M5.91%+3%1.26M3.7
Jun 30, 20264.49M5.74%-6%1.48M3.0
Jun 15, 20264.81M6.13%-5%1.40M3.4
May 29, 20265.08M6.49%-6%1.61M3.1
May 15, 20265.42M6.92%-14%1.92M2.8

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded PGNY

Since Nov 17, 2024, 1 member of Congress reported 0 purchases and 1 sale of PGNY. The latest was a sale by Josh Gottheimer on Dec 6, 2024, reported Jan 14, 2025.

Purchases 0Sales 1

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Dec 6, 2024Josh Gottheimer (D-NJ)Sale$1K–$15KJointJan 14, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Progyny company events

Progyny filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Aug 6, 2026ResultsReleased financial results. Filing
  3. May 27, 2026VoteReported shareholder vote results. Filing
  4. May 26, 2026AnnouncementProgyny, Inc. announced today that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. Filing
  5. May 7, 2026ResultsReleased financial results. Filing
  6. Mar 13, 2026AnnouncementProgyny, Inc. issued a Notice of Pendency of Settlement of Derivative Action, which is attached hereto as Exhibit 99.1, in accordance with the terms of a settlement agreement the Company entered into with a stockholder of the Company to resolve an action brought derivatively on behalf of the… Filing
  7. Feb 26, 2026ResultsReleased financial results. Filing
  8. Jan 12, 2026ResultsReleased financial results. Filing
  9. Dec 17, 2025LeadershipProgyny, Inc. announced that the employment of Michael Sturmer, the Company’s President, will cease, effective as of December 31, 2025. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Progyny financials

Famous investors that hold PGNY

4 of the 50 well-known investors we track reported holding PGNY in their latest 13F filing. The largest position is Ken Griffin's, worth $19.8M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026786,441$19.8M0.0%-56%
Israel Englander · Millennium ManagementQ3 2026392,292$9.9M0.0%-11%
Jim Simons · Renaissance TechnologiesQ3 2026290,467$7.3M0.0%-32%
Ray Dalio · Bridgewater AssociatesQ3 2026199,886$5M0.0%+286%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named PGNY in the last 120 days.

FiledHolderFormStake
Oct 27, 2026BlackRock, Inc.13G/A14.7%
Oct 27, 2026BlackRock, Inc.13G/A14.7%

Questions about Progyny, Inc. (PGNY) stock

Who owns the most PGNY stock?

The largest reported owner of Progyny, Inc. (PGNY) is BlackRock, Inc., with 14.8% of the company. In total, 311 funds and institutions reported holding PGNY at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are PGNY insiders buying or selling?

In the last 12 months, PGNY insiders reported no open-market purchases and 38 sales worth $24.5M. The latest trade was on Nov 11, 2026. See every trade.

What is the short interest in PGNY?

As of Oct 30, 2026, 4.76M PGNY shares were sold short, 6.2% of the shares outstanding, down 1.9% from the report before. At the average daily volume of 760,534 shares, buying them all back would take about 6.3 trading days (days to cover). See the history.

Have members of Congress traded PGNY?

Yes. 1 member of Congress reported 0 purchases and 1 sale of PGNY since Nov 17, 2024. The latest was reported on Jan 14, 2025. See the trades.

Which famous investors hold PGNY?

4 of the 50 well-known investors we track reported PGNY in their latest 13F filing, including Ken Griffin, Israel Englander, Jim Simons. The largest position is worth $19.8M. See all holders.

Executive pay

Progyny's chief executive was paid a total of $7.2M for the year ended Dec 31, 2025, up 430% from $1.4M the year before. In the last 12 months, Progyny's executives and directors bought $1.9M of stock on the open market and sold $24.5M.

Chief executive, total pay$7.2MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$10.3MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$2.1MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.